Exchange: NASDAQ·Updated 04:48 AM EDT

OCUPOcuphire Pharma Inc

$3.03
$0.02
(0.66%)
Pre-Market
Prev Close $3.05
EarningsAug 12
Mkt Cap$269.99M
Vol111.00

About

Opus Genetics, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Durham, NC.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
28

Frequently Asked Questions

What is Market Cap of Opus Genetics Inc.?
What is the 52-week high for Opus Genetics Inc.?
What is the 52-week low for Opus Genetics Inc.?
What is Opus Genetics Inc. stock price today?
What was Opus Genetics Inc. stock price yesterday?
What is the PE ratio of Opus Genetics Inc.?
What is the Price-to-Book ratio of Opus Genetics Inc.?
What is the 50-day moving average of Opus Genetics Inc.?
How many employees does Opus Genetics Inc. have?

Advertisement|Remove ads.